Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 5, 2013, Pages 633-635

  Nielsen, Hans Linde ^a   Engberg, Jorgen ^b   Ejlertsen, Tove ^a   Nielsen, Henrik ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b SLAGELSE HOSPITAL   (Denmark)

Author keywords

Calprotectin; Campylobacter concisus; Campylobacter jejuni; Diarrhea; Gastroenteritis

Indexed keywords

CALGRANULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER CONCISUS; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CHILD; FECES ANALYSIS; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHOOL CHILD; VERNER MORRISON SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENMARK; DIAGNOSIS, DIFFERENTIAL; FECES; FEMALE; GASTROENTERITIS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84876464455     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.775329     Document Type: Article

References (10)

1. Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodological study. Scand J Gastroenterol 1992; 27:793-8.
2. Shastri YM, Bergis D, Povse N, Schäfer V, Shastri S, Weindel M, et al. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med 2008;121:1099-106.
3. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.
4. Nielsen HL, Ejlertsen T, Engberg J, Nielsen H. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect 2012; Epub ahead of print.
5. Nielsen HL, Engberg J, Ejlertsen T, Bucker R, Nielsen H. Short-term and medium-term clinical outcomes of Campylo-bacter concisus infection. Clin Microbiol Infect 2012;18: E459-65.
6. Mahendran V, Riordan SM, Grimm MC, Tran TA, Major J, Kaakoush NO, et al. Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One 2011;6:e25417.
7. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. Detection of Campylobacter concisus and Other Campylobacter species in Colonic Biopsies from adults with Ulcerative Colitis. PLoS One 2011;6:e21490.
8. Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos-Portugal JA, Raftery MJ, et al. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One 2011;6:e29045.
9. Chen CC, Huang JL, Chang CJ, Kong MS. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr 2012;55:541-7.
10. Sykora J, Siala K, Huml M, Varvarovska J, Schwarz J, Pomahacova R. Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis. Acta Paediatr 2010;99: 1389-95.